Role of computerised continuous performance task tests in ADHD

Progress in Neurology and Psychiatry

Volumn 15, Issue 3, 2011, Pages 8-13

  Ogundele, Michael O ^a   Ayyash, Hani F ^b   Banerjee, Somnath ^c  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; METHYLPHENIDATE; NORADRENALIN TRANSPORTER; PLACEBO; PSYCHOSTIMULANT AGENT; SODIUM PROTON EXCHANGE PROTEIN;

AGE DISTRIBUTION; ANALYTICAL PARAMETERS; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUDITORY STIMULATION; BEHAVIORAL SCIENCE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COMPUTERISED CONTINUOUS PERFORMANCE TASK TEST; COST UTILITY ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; ENVIRONMENTAL FACTOR; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GOLD STANDARD; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; LEARNING DISORDER; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REACTION TIME; REVIEW; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STIMULUS RESPONSE; TASK PERFORMANCE; TEST RETEST RELIABILITY; TREATMENT DURATION; VALIDATION PROCESS; VISUAL STIMULATION;

EID: 79959229582     PISSN: 13677543     EISSN: 1931227X     Source Type: Journal    
DOI: 10.1002/pnp.198     Document Type: Review

References (32)

1. World Health Organization. International Classification of Diseases, 10th edn. Geneva: WHO, 1993.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington DC: APA, 1994.
3. National Institute for Health and Clinical Excellence (NICE). Guideline for attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults (final scope). London: NICE, 2006. http://www.nice.org.uk/nicemedia/pdf/ADHDFinalScope.pdf
4. Weinberg WA, Brumback RA. The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes. J Child Neurology 1992;7(4):431-45.
5. DuPaul GJ, Anastopoulos AD, Shelton TL, Guevremont D. Multimethod assessment of attention-deficit hyperactivity disorder: the diagnostic utility of clinic-based tests. J Clin Child Psychol 1992;21(4):394-402.
6. Emergency Care Research Institute (ECRI) Continuous Performance Tests (CPTs) for Diagnosis and Titration of Medication for Attention Deficit Hyperactivity Disorder (ADHD). Plymouth Meeting, PA: ECRI, 2000. http://ablechild.org/right%20to%20refuse/continuous_ performance_tests.htm
7. Grunebaum H, Weiss JL, Gallant D, Cohler BJ. Attention in young children of psychotic mothers. Am J Psychiatry 1974;131(8):887-91.
8. Uno M, Abe J, Sawai C, et al. Effect of additional auditory and visual stimuli on continuous performance test (noise-generated CPT) in AD/HD children - usefulness of noise-generated CPT. Brain and Development 2006;28(3):162-9.
9. Conners CK, Epstein JN, Angold A, Klaric, J. Continuous performance test performance in a normative epidemiological sample. J Abnormal Child Psychol 2003;31(5):555-62.
10. Anastasi A. Psychological Testing. 6th edn. New York: Macmillan Publishing Company, 1988;817.
11. Raggio DJ, Rhodes RL, Whitten JD. Factor analysis of the continuous performance test and parent-teacher reports of attention deficit disorder. Psychology Report 1999;85(3 Pt 1):935-41.
12. Pan XX, Ma HW, Dai XM. Value of integrated visual and auditory continuous performance test in the diagnosis of childhood attention deficit hyperactivity disorder. [Article in Chinese] Chinese J Contemporary Pediatrics [Zhongguo dang dai er ke za zhi] 2007;9(3):210-2.
13. Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychology Psychiatry 1996;37(8):971-87.
14. Epstein JN, Conners CK, Hervey AS, et al. MTA Cooperative Study Group. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry 2006;47(5):446-56.
15. Soreni N, Crosbie J, Ickowicz A, Schachar R. Stop signal and Conners' continuous performance tasks: test - retest reliability of two inhibition measures in ADHD children. Journal of Attention Disorders 2009;13(2):137-43.
16. Fernández-Jaén A, Fernández-Mayoralas DM, Pardos A, et al. Clinical and cognitive response to extended-release methylphenidate (Medikinet(R) in attention deficit/hyperactivity disorder: Efficacy evaluation. Advances in Therapy 2009;26(12):1097-110.
17. Huang YS, Chao CC, Wu YY, et al. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder. Psychiatry and Clin Neurosci 2007;61(3):219-25.
18. Seifert J. Scheuerpflug P, Zillessen KE, et al. Electrophysiological investigation of the effectiveness of methylphenidate in children with and without ADHD. J Neural Transmission 2003;110(7):821-9.
19. Tillery KL, Katz J, Keller WD. Effects of methylphenidate (Ritalin) on auditory performance in children with attention and auditory processing disorders. J Speech Language and Hearing Res 2000;43(4):893-901.
20. Aggarwal A, Lillystone D. A follow-up pilot study of objective measures in children with attention deficit hyperactivity disorder. J Paediatrics Child Health 2000;36(2):134-8.
21. Solanto M, Newcorn J, Vail L, et al. Stimulant drug response in the predominantly inattentive and combined subtypes of attentiondeficit/ hyperactivity disorder. J Child Adolescent Psychopharmacol 2009;19(6):663-71.
22. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry and Clin Neurosci 2001;13(3): 326-35.
23. Heiser P, Frey J, Smidt J, et al. Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. European Child and Adolescent Psychiatry 2004;13(2):100-4.
24. Markunas CA, Quinn KS, Collins AL, et al. Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families. Psychiatric Genetics 2010;20(2): 73-81.
25. Kollins SH, McClernon FJ, Epstein JN. Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis. Drug and Alcohol Dependence 2009;100(1-2):1 69-72.
26. Kim B, Koo MS, Jun JY, et al. Association between dopamine D4 receptor gene polymorphism and scores on a continuous performance test in Korean children with attention deficit hyperactivity disorder. Psychiatry Investigation 2009;6(3):216-21.
27. Kebir O, Tabbane K, Sengupta S, Joober R. Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci 2009;34(2):88-101.
28. Rubia K, Overmeyer S, Taylor E, et al. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 1999;156(6):891-6.
29. Durston S, Tottenham NT, Thomas KM, et al. Differential patterns of striatal activation in young children with and without ADHD. Biol Psychiatry 2003;53(10):871-8.
30. Baumeister AA, Hawkins MF. Incoherence of neuroimaging studies of attention deficit/hyperactivity disorder. Clin Neuropharmacol 2001;24(1):2-10.
31. Li F, Li BJ, Hu DW, et al. [Article in Chinese]. Chinese J Contemporary Paediatrics [Zhongguo dang dai er ke za zhi] 2010;12(1):24-8.
32. Riccio CA, Cohen MJ, Hynd GW, Keith RW. Validity of the auditory continuous performance test in differentiating central processing auditory disorders with and without ADHD. J Learning Disabilities 1996;29(5):561-6.